3154 related articles for article (PubMed ID: 7691291)
21. Immunohistochemical analysis of cutaneous malignant melanoma: comparison of S-100 protein, HMB-45 monoclonal antibody and NKI/C3 monoclonal antibody.
Fernando SS; Johnson S; Bäte J
Pathology; 1994 Jan; 26(1):16-9. PubMed ID: 8165017
[TBL] [Abstract][Full Text] [Related]
22. Expression of CALLA/CD10 on human melanoma cells.
Carrel S; Zografos L; Schreyer M; Rimoldi D
Melanoma Res; 1993 Oct; 3(5):319-23. PubMed ID: 8292887
[TBL] [Abstract][Full Text] [Related]
23. Antigen expression of metastasizing and non-metastasizing human melanoma cells xenografted into nude mice.
Van Muijen GN; Cornelissen LM; Jansen CF; Figdor CG; Johnson JP; Bröcker EB; Ruiter DJ
Clin Exp Metastasis; 1991; 9(3):259-72. PubMed ID: 2060184
[TBL] [Abstract][Full Text] [Related]
24. Monitoring of tumor reoxygenation following irradiation by 31P magnetic resonance spectroscopy: an experimental study of human melanoma xenografts.
Olsen DR; Rofstad EK
Radiother Oncol; 1999 Sep; 52(3):261-7. PubMed ID: 10580874
[TBL] [Abstract][Full Text] [Related]
25. Monoclonal antibodies directed against epitopes within the core protein structure of the large aggregating proteoglycan (aggrecan) from the swarm rat chondrosarcoma.
Calabro A; Hascall VC; Caterson B
Arch Biochem Biophys; 1992 Nov; 298(2):349-60. PubMed ID: 1384430
[TBL] [Abstract][Full Text] [Related]
26. Differential expression of proteoglycans on the surface of human melanoma cells characterized by altered experimental metastatic potential.
Timar J; Ladanyi A; Lapis K; Moczar M
Am J Pathol; 1992 Aug; 141(2):467-74. PubMed ID: 1379782
[TBL] [Abstract][Full Text] [Related]
27. Monoclonal antibody-directed effector cells selectively lyse human melanoma cells in vitro and in vivo.
Schulz G; Bumol TF; Reisfeld RA
Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5407-11. PubMed ID: 6577434
[TBL] [Abstract][Full Text] [Related]
28. Membrane-associated chondroitin sulfate proteoglycans of human lung fibroblasts.
David G; Lories V; Heremans A; Van der Schueren B; Cassiman JJ; Van den Berghe H
J Cell Biol; 1989 Mar; 108(3):1165-73. PubMed ID: 2646307
[TBL] [Abstract][Full Text] [Related]
29. Molecular cloning of a human melanoma-associated chondroitin sulfate proteoglycan.
Pluschke G; Vanek M; Evans A; Dittmar T; Schmid P; Itin P; Filardo EJ; Reisfeld RA
Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9710-5. PubMed ID: 8790396
[TBL] [Abstract][Full Text] [Related]
30. Monoclonal antibodies in detection of choroidal melanoma.
Ringens PJ; van Haperen R; Vennegoor C; de Jong PT; van Duinen SG; Ruiter DJ; van der Kamp AW
Graefes Arch Clin Exp Ophthalmol; 1989; 227(3):287-90. PubMed ID: 2661335
[TBL] [Abstract][Full Text] [Related]
31. Chondroitin-6-sulfate-containing proteoglycan: a new component of human skin dermoepidermal junction.
Fine JD; Couchman JR
J Invest Dermatol; 1988 Mar; 90(3):283-8. PubMed ID: 3279132
[TBL] [Abstract][Full Text] [Related]
32. Expression of the co-stimulatory molecule CD40 on melanoma cells.
Thomas WD; Smith MJ; Si Z; Hersey P
Int J Cancer; 1996 Dec; 68(6):795-801. PubMed ID: 8980186
[TBL] [Abstract][Full Text] [Related]
33. Up-regulation of growth hormone receptor immunoreactivity in human melanoma.
Lincoln DT; Sinowatz F; Kölle S; Takahashi H; Parsons P; Waters M
Anticancer Res; 1999; 19(3A):1919-31. PubMed ID: 10470136
[TBL] [Abstract][Full Text] [Related]
34. Naturally occurring mouse antibodies against T-cell-secreted chondroitin sulphate proteoglycan.
Levitt D
Immunology; 1988 Aug; 64(4):587-92. PubMed ID: 3049320
[TBL] [Abstract][Full Text] [Related]
35. Establishment and characterization of six human melanoma xenograft lines.
Rofstad EK; Wahl A; Stokke T; Nesland JM
APMIS; 1990 Oct; 98(10):945-53. PubMed ID: 2245014
[TBL] [Abstract][Full Text] [Related]
36. Two human melanoma cell-line variants with enhanced in vivo tumor growth and metastatic capacity do not express the beta 3 integrin subunit.
Boukerche H; Benchaibi M; Berthier-Vergnes O; Lizard G; Bailly M; Bailly M; McGregor JL
Eur J Biochem; 1994 Mar; 220(2):485-91. PubMed ID: 8125107
[TBL] [Abstract][Full Text] [Related]
37. Isolation and characterization of a heterodimeric surface antigen on human melanoma cells and evidence that it is the 4F2 cell activation/proliferation molecule.
Dixon WT; Sikora LK; Demetrick DJ; Jerry LM
Int J Cancer; 1990 Jan; 45(1):59-68. PubMed ID: 2404879
[TBL] [Abstract][Full Text] [Related]
38. Epidermal and hair follicle progenitor cells express melanoma-associated chondroitin sulfate proteoglycan core protein.
Ghali L; Wong ST; Tidman N; Quinn A; Philpott MP; Leigh IM
J Invest Dermatol; 2004 Feb; 122(2):433-42. PubMed ID: 15009727
[TBL] [Abstract][Full Text] [Related]
39. In vitro targeting of NG2 antigen by 213Bi-9.2.27 alpha-immunoconjugate induces cytotoxicity in human uveal melanoma cells.
Li Y; Wang J; Rizvi SM; Jager MJ; Conway RM; Billson FA; Allen BJ; Madigan MC
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4365-71. PubMed ID: 16303921
[TBL] [Abstract][Full Text] [Related]
40. Immunoelectron microscopic localization of hyaluronic acid-binding region and link protein epitopes in brain.
Ripellino JA; Margolis RU; Margolis RK
J Cell Biol; 1989 May; 108(5):1899-907. PubMed ID: 2469681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
